SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indrayani Biotech - Quaterly Results

12 Jun 2025 Evaluate
The sales moved down -41.24% to Rs. 92.83 millions for the March 2025 quarter as compared to Rs. 157.99 millions during the corresponding quarter last year.The company almost doubled its revenue to Rs. 11.13 millions  from Rs. 0.72 millions in the quarter ended March 2025.Operating profit for the quarter ended March 2025 decreased to 26.60 millions as compared to 44.51 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 92.83 157.99 -41.24 377.69 623.23 -39.40 377.69 623.23 -39.40
Other Income 9.34 34.46 -72.90 35.16 36.19 -2.85 35.16 36.19 -2.85
PBIDT 26.60 44.51 -40.24 89.92 92.84 -3.15 89.92 92.84 -3.15
Interest 23.95 24.72 -3.11 73.21 48.28 51.64 73.21 48.28 51.64
PBDT 2.65 19.79 -86.61 16.71 44.56 -62.50 16.71 44.56 -62.50
Depreciation 0.64 3.55 -81.97 10.25 14.48 -29.21 10.25 14.48 -29.21
PBT 2.01 16.24 -87.62 6.46 30.08 -78.52 6.46 30.08 -78.52
TAX -9.12 15.52 -158.76 -8.00 15.52 -151.55 -8.00 15.52 -151.55
Deferred Tax -8.00 10.10 -179.21 -8.00 10.10 -179.21 -8.00 10.10 -179.21
PAT 11.13 0.72 1445.83 14.46 14.56 -0.69 14.46 14.56 -0.69
Equity 455.36 455.36 0.00 455.36 455.36 0.00 455.36 455.36 0.00
PBIDTM(%) 28.65 28.17 1.71 23.81 14.90 59.82 23.81 14.90 59.82

Indrayani Biotech Share Price

12.08 -0.06 (-0.49%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Grasim Industries 2757.45
DCM Shriram 1198.95
3M India 31427.05
Hindustan Foods 494.80
Balmer Lawrie & Co 177.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×